| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP Clinical Reg Affairs | VP Clinical Reg. Affairs
1 company
Thompson Jaye is a VP Clinical Reg Affairs at GLSI. Recent filings cover 21 purchases and 0 sales. Those positions are worth an estimated $3.4M at current prices.
Our model assigns Thompson Jaye a middling insider score of 53/100, based on 21 past trades. Over a 12-month horizon, 38.1% of those trades were profitable, with an average 12-month return of -2.9%.
Thompson Jaye's largest disclosed position is in GLSI as VP Clinical Reg Affairs, worth about $3.4M. Net of sales, the recent Form 4 record there shows accumulation of 11,150 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $12.91 | $12,910.00 | +0.4% | -2.9% | -37.2% | |
| Aug 12, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 800 | $13.85 | $11,080.00 | +0.3% | +5.1% | -7.7% | |
| Aug 2, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $15.15 | $15,150.00 | +0.4% | -6.3% | -22.8% | |
| Jul 18, 2024 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $16.00 | $16,000.00 | +0.4% | -10.0% | -25.4% | |
| Oct 27, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 500 | $8.57 | $4,285.00 | +0.2% | +3.5% | +58.5% | |
| Sep 26, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 600 | $8.71 | $5,226.00 | +0.2% | +29.8% | +77.6% | |
| Jul 13, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $9.49 | $2,372.50 | - | -4.2% | +65.3% | |
| Apr 28, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $11.22 | $2,805.00 | - | -16.5% | +22.5% | |
| Apr 11, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 1,000 | $11.87 | $11,870.00 | +0.4% | -25.4% | +29.6% | |
| Mar 15, 2023 | GLSI Greenwich Lifesciences, Inc. | VP Clinical Reg Affairs | Buy | 250 | $12.71 | $3,177.50 | - | -13.4% | +27.8% |